---
figid: PMC6539103__ijms-20-02243-g002
figlink: /pmc/articles/PMC6539103/figure/ijms-20-02243-f002/
number: F2
caption: The potential roles of aberrant activations of MAPK and PI3K signaling pathways
  in pathogenesis of PWS/SWS. Mutations in GNAQ, EphB4, RASA1, Tie2 and other genes,
  as well as co-expression of EphB1/EfnB2 lead to an activation of MAPK. Mutation
  in PIK3CA (G1049N) activates AKT/mTOR pathway. Overexpression of VEGF-A and VEGFR2
  can activate in MAPK and AKT/mTOR. Altogether, these factors lead to aberrant activations
  of MAPK and PI3K signaling pathways, thus result in cell proliferation, migration,
  survival, cytoskeletal arrangement and vasopermeability, eventually causing development
  of PWS/SWS. Some anti-angiogenesis compounds or antibodies that are under development
  or have been approved by FDA are listed in the figure for potential treatments of
  vascular malformations.
pmcid: PMC6539103
papertitle: 'The Pathogenesis of Port Wine Stain and Sturge Weber Syndrome: Complex
  Interactions between Genetic Alterations and Aberrant MAPK and PI3K Activation.'
reftext: Vi Nguyen, et al. Int J Mol Sci. 2019 May;20(9):2243.
pmc_ranked_result_index: '100804'
pathway_score: 0.9407785
filename: ijms-20-02243-g002.jpg
figtitle: Potential roles of aberrant activations of MAPK and PI3K signaling pathways
  in pathogenesis of PWS/SWS
year: '2019'
organisms: Homo sapiens
ndex: c4f20567-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6539103__ijms-20-02243-g002.html
  '@type': Dataset
  description: The potential roles of aberrant activations of MAPK and PI3K signaling
    pathways in pathogenesis of PWS/SWS. Mutations in GNAQ, EphB4, RASA1, Tie2 and
    other genes, as well as co-expression of EphB1/EfnB2 lead to an activation of
    MAPK. Mutation in PIK3CA (G1049N) activates AKT/mTOR pathway. Overexpression of
    VEGF-A and VEGFR2 can activate in MAPK and AKT/mTOR. Altogether, these factors
    lead to aberrant activations of MAPK and PI3K signaling pathways, thus result
    in cell proliferation, migration, survival, cytoskeletal arrangement and vasopermeability,
    eventually causing development of PWS/SWS. Some anti-angiogenesis compounds or
    antibodies that are under development or have been approved by FDA are listed
    in the figure for potential treatments of vascular malformations.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - PTEN
  - MAPK8
  - AKT3
  - MAP2K1
  - MAPK3
  - AKT1
  - BRAF
  - MAPK1
  - NMUR1
  - PTK2
  - GIP
  - GNAQ
  - AKT2
  - RASA1
  - SRC
  - TEK
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - ARAF
  - RAF1
  - MAPK9
  - KRAS
  - MAP2K2
  - PDGFRB
  - FLT1
  - FLT4
  - PDGFRA
  - HRAS
  - MAPK10
  - KDR
  - NRAS
  - Axitinib Sorafenib
  - Ga
  - Linifanib
  - GDP
  - Sorafenib
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PTEN-
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: GIP
  symbol: GIP
  source: hgnc_symbol
  hgnc_symbol: GIP
  entrez: '2695'
- word: GNAQ
  symbol: GNAQ
  source: hgnc_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RASA1
  symbol: RASA1
  source: hgnc_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: TIE2/RTK
  symbol: TIE-2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: KRas
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: VEGFR/PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: VEGFR/PDGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR/PDGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR/PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: VEGFR/PDGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals:
- word: Axitinib Sorafenib
  source: MESH
  identifier: C503983
- word: Ga
  source: MESH
  identifier: C043055
- word: Linifanib
  source: MESH
  identifier: C513486
- word: GDP
  source: MESH
  identifier: D006153
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6539103__F2
redirect_from: /figures/PMC6539103__F2
figtype: Figure
---
